The Scleroderma Foundation of Southern California’s 17th annual “Key to a Cure” gala, Genentech‘s Senior Group Medical Director of Immunology, Dr. Jeffrey Siegel, will receive the honor of the Spirit of Leadership Award. The award is given to prominent individuals who have contributed to the scientific and clinical communities’ progress in the realm of developing treatments for scleroderma. With more than 20 years of experience working in the field of scleroderma research at the Food and Drug Administration (FDA) and Genentech, Dr. Siegelhas helped with the review and approval processes behind multiple rheumatic disease therapies.